Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema

Xiao-hua Ling; Xin Yu; De-jun Kong; Cheng-yi Hu; Yu Hong; Xiao-ming Yang

doi:10.1007/s11655-010-0222-0

Your Location：

Home >

Browse articles >

Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema

Updated：2021-08-27

- Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema
- Chinese Journal of Integrative Medicine Vol. 16, Issue 3, Pages: 222-228(2010)
- Affiliations：
  
  1. Department of Digestive Diseases, The 4th Hospital Affiliated to Harbin Medical University,Harbin,China
  2. The second Affiliated Hospital of Harbin Medical University,Harbin,China
  3. Department of Pathology, the 4th Hospital Affiliated to Harbin Medical University,Harbin,China
- Author bio：
- Funds：
  
  Supported by Heilongjiang Administration of Traditional Chinese Medicine
- DOI：10.1007/s11655-010-0222-0
  CLC：
- Published：2010，
  
  Published Online：8 August 2010，
Scan for full text
Ling, Xh., Yu, X., Kong, Dj. et al. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema., Chin. J. Integr. Med. 16, 222–228 (2010). https://doi.org/10.1007/s11655-010-0222-0

Xiao-hua Ling, Xin Yu, De-jun Kong, et al. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema. [J]. Chinese Journal of Integrative Medicine 16(3):222-228(2010)
Ling, Xh., Yu, X., Kong, Dj. et al. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema., Chin. J. Integr. Med. 16, 222–228 (2010). https://doi.org/10.1007/s11655-010-0222-0 DOI：

Xiao-hua Ling, Xin Yu, De-jun Kong, et al. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema. [J]. Chinese Journal of Integrative Medicine 16(3):222-228(2010) DOI： 10.1007/s11655-010-0222-0.

摘要

To study the clinical effect of Chinese drugs administered by both oral intake and retention enema on inflammatory bowel diseases (IBD). Adopting a randomized controlled design

78 patients were assigned to three groups: 26 patients in group A treated with Chinese drugs given by both oral intake and retention enema

27 in group B with Chinese drugs given by retention enema only

and 25 in group C with given Western medicine. The changes before and after a 30-day treatment of the patients’ symptoms (including diarrhea

abdominal pain

mucous or pus-bloody stool)

colonoscopic examination scores and histopathology of the colonic membrane were observed. Group A showed the best outcomes in all the aspects of clinical comprehensive effectiveness. Improvements in the main symptoms

colonoscopic scores and histopathology of the colonic membrane were significantly different from those in groups B and C

respectively (P<0.05). Meanwhile comparisons between groups B and C showed insignificant differences (P>0.05); group B was better in ameliorating tenesmus (P<0.05). Through the use of Chinese drugs administered by both oral intake and retention enema to treat IBD

which combined external-internal therapies for both overall regulation and local managment

it was confirmed that the Chinese medicine could embody the therapeutic principle of attending to both disease-diagnosis and syndrome-differentiation.

Abstract

To study the clinical effect of Chinese drugs administered by both oral intake and retention enema on inflammatory bowel diseases (IBD). Adopting a randomized controlled design

78 patients were assigned to three groups: 26 patients in group A treated with Chinese drugs given by both oral intake and retention enema

27 in group B with Chinese drugs given by retention enema only

and 25 in group C with given Western medicine. The changes before and after a 30-day treatment of the patients’ symptoms (including diarrhea

abdominal pain

mucous or pus-bloody stool)

colonoscopic scores and histopathology of the colonic membrane were significantly different from those in groups B and C

which combined external-internal therapies for both overall regulation and local managment

it was confirmed that the Chinese medicine could embody the therapeutic principle of attending to both disease-diagnosis and syndrome-differentiation.

关键词

Inflammatory Bowel Diseaseouter-inner combined therapyRetention EnemaClinical Study

Keywords

Inflammatory Bowel Diseaseouter-inner combined therapyRetention EnemaClinical Study

references

Wang FY. Effect of incidence, prevalence and environmental factors in inflammatory bowel disease. Chin J Social Med (Chin) 2007;24:138–139.

Lakatos PL. Recent trends in the epidemiology of inflammatory bowel disease, Up or down? World J Gastroenterol 2006;12:6102–6108.

Chen ZS, Wei BH, Chen ZM. Diagnosis, syndrome differentiation and efficacy standards of integrative medicine in chronic non-specific ulcerative colitis (trial). Chin J Integr Tradit West Med (Chin) 1994;14:239–240.

Chinese Society of Gastroenterology. Suggestion on diagnosis and treatment standard of inflammatory bowel disease. Chin J Dig (Chin) 2001;21:56–59.

Xie JL, Steven HI. Cancer in inflammatory bowel disease. World J Gastroenterol 2008;14:378–389.

Ran ZH, Shen J. New concepts in the treatment of inflammatory bowel disease. Chin J Gastroenterol (Chin) 2009;14:69–73.

Zhao RR, ed. Clinical pharmacy. (1st ed). Beijing: Beijng Publishing Group LTD.; 2000:634–635.

Ling XS, Wang XK, Chen DS. Internal medicine of integrative medicine. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2001:466.

Wu J, Shan ZW. Retrospective analysis of 115 cases IBD patients treated and etiopathology by TCM view. Pract Clini J Integr Tradit Chin West Med (Chin) 2004;4:4–6

Yang QX, Yang JY, Qu CF, Li DJ, Wang H, Xi XY, et al. Enflunce of membranous milkvetch root on guina pig of type I hypersensitivity. Chin J Microecol (Chin) 2002;14:17–18.

Shi YQ. Current research in cytokines of immune regulation and inflammatory bowel disease. Med J Communications (Chin) 2009;23:310–313.

FULL TEXT LINK

More>

Views

338

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

Oral herbal medicines for psoriasis: A review of clinical studies

Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease

Alleviation of cancerous pain by external compress with Xiaozheng Zhitong Paste (消癥止痛方)

Clinical observation on the treatment of chronic severe hepatitis B by retention enema with Huchang Jiedu Decoction (护肠解毒汤)

Related Author

No data

Related Institution

Shanghai University of Traditional Chinese Medicine

Guangdong Provincial Academy of Chinese Medical Sciences and Guangdong Provincial Hospital of Chinese Medicine

School of Health Sciences, RMIT University, Bundoora

WHO Collaborating Centre for Traditional Medicine

Traditional & Complementary Medicine Research Program, Health Innovations Research Institute

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰